Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I study of the oncolytic virus DNX-2401 in diffuse intrinsic pontine glioma

Sep. 25, 2019

Nanobiotix presents phase I data from phase I/II study of NBTXR-3 in HCC

Sep. 25, 2019

Positive topline results presented from phase II STAR study of tolperisone

Sep. 25, 2019

PhoenixMD receives FDA clearance to initiate phase I/Ib study of PMD-026

Sep. 25, 2019

Phase III study of StrataGraft regenerative tissue meets both primary endpoints

Sep. 25, 2019

Ovid announces positive initial data from ongoing ENDYMION extension trial of soticlestat

Sep. 25, 2019

European Commission approves Epidyolex for the treatment of LGS and Dravet syndrome

Sep. 25, 2019

Senolytics work as advertised

Sep. 25, 2019

GABA Therapeutics and ATAI Life Sciences to develop GRX-917 for the treatment of mood disorders

Sep. 25, 2019

Crysvita approved in Japan for FGF-23-related hypophosphatemic rickets and osteomalacia

Sep. 23, 2019

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...